Brought to you by:
Jimenez joins JVS-CIT as DEI editor
The Journal of Vascular Surgery-Cases, Innovations and Techniques (JVS-CIT) has appointed Juan Carlos Jimenez, MD, as its new associate editor and diversity, equity and inclusion (DEI) officer. Jimenez, who serves as clinical professor of surgery and director of the Gonda…
Increasing access and decreasing scientific bias: How open access is changing academic publishing
There has been much talk recently on open access publishing and the costs associated with this mode of publication. While editor-in-chief positions within most scientific journals are academic roles involved with the overall content published within journals and not the…
JVS-CIT releases special issue on genetic arteriopathy
The Journal of Vascular Surgery Cases, Innovations and Techniques (JVS-CIT) has published its latest virtual special issue, which covers genetic arteriopathy. This is the second special issue published in the journal. JVS-CIT currently plans to publish four per year. JVS-CIT…
FDA clears AAA-SHAPE trial for IDE approval
Shape Memory Medical recently announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the Impede-FX RapidFill device to…
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter Gloviczki, MD, and Senior Editor Peter Lawrence, MD, ended their six-year run as editors of all…